Communiqués DSS, Inc.

Actions

DSS

US26253C2017

Emballages papier

Marché Fermé - NYSE 22:10:00 21/09/2026			Varia. 5j.	Varia. 1 janv.
0,7385 ^USD	+5,33 %		-3,08 %	-20,40 %

08/09	DSS, Inc. lance DSS Robotics et annonce des solutions d'automatisation basées sur l'IA pour les entreprises	CI
04/09	Les plus fortes baisses en avant-Bourse	MT

Communiqués

08/09	DSS, Inc. Launches DSS Robotics to Bring AI-Powered Automation to Enterprise Operations	AQ
04/09	DSS, Inc. Announces Decision Not to Proceed with Proposed Public Offering	AQ
04/09	DSS, Inc. Announces Launch of Proposed Public Offering	AQ
09/06	DSS, Inc. Withdraws Registration Statement	AQ
08/05	DSS, Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing	AQ
15/04	DSS, Inc. Letter to Shareholders	AQ
05/02	DSS, Inc. Announces Closing of $1.0 Million Underwritten Public Offering	AQ
04/02	DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering	AQ
04/02	DSS, Inc. Announces Launch of Proposed Public Offering	AQ
24/06/25	DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger	AQ
22/05/25	DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth	AQ
24/04/25	Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings	AQ
03/02/25	DSS, Inc. Issues Letter to Shareholders	AQ
14/11/24	DSS : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
22/10/24	DSS : Non Reliance of Financial Report Form 8 K	PU
22/10/24	DSS : Amendment to Annual Report Form 10 K/A	PU
16/09/24	DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value	AQ
10/09/24	AmericaFirst Funds Trust Announces Changes to Board of Trustees	AQ
26/08/24	DSS, Inc. Names Jason Grady as Interim Chief Executive Officer	AQ
30/01/24	Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."	AQ
04/01/24	DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market	AQ
22/12/23	DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan	AQ
28/11/23	Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years	AQ
15/11/23	Impact Biomedical Inc. Files Current Report on Form 8-K	AQ
14/11/23	DSS Inc. Wins Patent Dispute with Nichia Corporation	AQ